Nuwellis Inc vs Visa Inc — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while Visa Inc trades at $356.3 (market cap $685.71B). The key difference: Visa Inc is far larger — about 629091.7× Nuwellis Inc's market cap, and Visa Inc pays a 0.74% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | V | |
|---|---|---|
Market Cap | $1.09M | $685.71B |
Sector | Technology | Financials |
52-Week High | $527.46 | $365.14 |
52-Week Low | $2.80 | $295.52 |
Enterprise Value | -$722.58K | $696.30B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.74% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Visa (V) trades at $355.82, down 0.76% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $396.70. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $3.31 exceeding expectations. Revenue reached $40 billion in 2025, and net income margin stands at 51.68%, reflecting robust profitability. Recent news highlights Visa's expansion into AI-driven commerce and stablecoin partnerships, positioning it for future growth in digital payments.
Visa presents a favorable long-term investment opportunity due to its dominant market position, consistent earnings growth, and high profitability. Key risks include competitive pressures from fintech and regulatory scrutiny. With 85% of analysts rating it a buy and institutional ownership increasing, the stock offers upside potential, though investors should monitor execution on AI initiatives and macroeconomic factors affecting consumer spending.
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →